The Anti-apoptotic Activities of Rel and RelA Required During B-cell Maturation Involve the Regulation of Bcl-2 Expression
Overview
Molecular Biology
Affiliations
Rel and RelA, individually dispensable for lymphopoiesis, serve unique functions in activated B and T cells. Here their combined roles in lymphocyte development were examined in chimeric mice repopulated with c-rel(-/-) rela(-/-) fetal liver hemopoietic stem cells. Mice engrafted with double-mutant cells lacked mature IgM(lo)IgD(hi) B cells, and numbers of peripheral CD4(+) and CD8(+) T cells were markedly reduced. The absence of mature B cells was associated with impaired survival that coincided with reduced expression of bcl-2 and A1. bcl-2 transgene expression not only prevented apoptosis and increased peripheral B-cell numbers, but also induced further maturation to an IgM(lo)IgD(hi) phenotype. In contrast, the survival of double-mutant T cells was normal and the bcl-2 transgene could not rectify the peripheral T-cell deficit. These findings indicate that Rel and RelA serve essential, albeit redundant, functions during the later antigen-independent stages of B- and T-cell maturation, with these transcription factors promoting the survival of peripheral B cells in part by upregulating Bcl-2.
The role of NF-κB-SOX9 signalling pathway in osteoarthritis.
Tian B, Zhang L, Zheng J, Kang X Heliyon. 2024; 10(17):e37191.
PMID: 39319133 PMC: 11419907. DOI: 10.1016/j.heliyon.2024.e37191.
Pakjoo M, Ahmadi S, Zahedi M, Jaafari N, Khademi R, Amini A Cell Commun Signal. 2024; 22(1):105.
PMID: 38331801 PMC: 10851565. DOI: 10.1186/s12964-023-01433-5.
The TRIM21-FOXD1-BCL-2 axis underlies hyperglycaemic cell death and diabetic tissue damage.
Cheng W, Cai C, Xu Y, Xiao X, Shi T, Liao Y Cell Death Dis. 2023; 14(12):825.
PMID: 38092733 PMC: 10719266. DOI: 10.1038/s41419-023-06355-1.
NF-kB's contribution to B cell fate decisions.
Guldenpfennig C, Teixeiro E, Daniels M Front Immunol. 2023; 14:1214095.
PMID: 37533858 PMC: 10391175. DOI: 10.3389/fimmu.2023.1214095.
Melchor J, Garcia-Lacarte M, Grijalba S, Arnaiz-Leche A, Pascual M, Panizo C J Immunother Cancer. 2023; 11(2).
PMID: 36854569 PMC: 9980368. DOI: 10.1136/jitc-2022-006113.